- CA$11.51m
- CA$8.53m
- CA$5.05m
- 78
- 86
- 44
- 78
C2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3.68 | 5.04 | 3.71 | 4.37 | 5.05 |
Cost of Revenue | |||||
Gross Profit | 2.11 | 2.56 | 2.49 | 2.68 | 3.04 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 3.44 | 4.46 | 3.15 | 3.77 | 4.28 |
Operating Profit | 0.246 | 0.577 | 0.557 | 0.605 | 0.77 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.231 | 0.713 | 0.449 | 0.567 | 0.863 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.231 | 0.713 | 0.449 | 0.567 | 3.69 |
Net Income Before Extraordinary Items | |||||
Net Income | 0.231 | 0.713 | 0.449 | 0.567 | 3.69 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.231 | 0.713 | 0.449 | 0.567 | 3.69 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.008 | 0.023 | 0.017 | 0.018 | 0.122 |